Media Thread, page-13598

It really does not matter whether RR is real or not.

What matters for a research biotech investor is official company announcement of facts. And what the FDA does. So far, all announcements with regards to Vaxinia has been great. It is treating patients that have no chance at all. One CR, one PR and 17 SDs. All of them should be dead already but here we are.

And if that is not enough, the FDA even gave Fast Track Designation for Vaxinia to treat bile duct cancer. Would the FDA even consider this, if CF33 is truly toxic and the ongoing trial is going badly as some claimed?

And there you have it. A research biotech investors should not take anything else with too much import other than official company announcements of facts and FDA actions. Anything else, just read for fun. Even my own speculation is for fun to help past the time. After all, investing in biotech is truly a very boring game as there is silence for long periods of time.